SD

Bacteria Neisseria gonorrhoeae
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Phase III trial #SD

Gonorrhoea treatment could combat resistant infections

Newly published Phase III trial results suggest the new antibiotic gepotidacin could treat uncomplicated urogenital gonorrhoea (GC).  The trial showed that gepotidacin was non-inferior with 92.6% success rates when compared to 91.2% success rates for intramuscular ceftriaxone plus oral azithromycin combined therapy, a leading combination treatment… Read More

#News